Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.16−0.01 (-7.03%)
Close on Nov 12, 2026Market cap $120.89KP/E –Yield –
Endovia Health Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Endovia Health Sciences's ebitda for the twelve months ending Mar 31, 2026 was -$12.99M. For fiscal 2025 it was -$14.18M. The highest annual figure on record is -$4.48M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.18M | – |
| FY2024 | Dec 31, 2024 | -$9.50M | – |
| FY2023 | Dec 31, 2023 | -$14.74M | – |
| FY2022 | Dec 31, 2022 | -$20.46M | – |
| FY2021 | Dec 31, 2021 | -$28.97M | – |
| FY2020 | Dec 31, 2020 | -$17.55M | – |
| FY2019 | Dec 31, 2019 | -$4.48M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$976.65K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$293.35K | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.53M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.19M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.78M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.16M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.70M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.47M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.15M | – |
| Q2 FY2020 | Jun 30, 2020 | -$404.73K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.55M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$859.23K | – |
| Q2 FY2019 | Jun 30, 2019 | -$306.35K | – |
| Q1 FY2019 | Mar 31, 2019 | -$445.58K | – |
See a number that looks wrong?